{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2021"],"condition":["Colorectal cancer metastatic","Metastases from Colorectal Cancer"],"disease":["Colorectal Cancer Metastatic","Metastases From Colorectal Cancer"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2540825"],"location":["Norway"],"study_start_month":["3"],"keyword":["Oksaliplatin"],"repository":["ECRIN MDR"],"study_status":["Ongoing"],"additional_accession":[]},"is_claimable":false,"name":"NORMOTHERMIC INTRAPERITONEAL CHEMOTHERAPY IN PERITONEAL METASTASES FROM COLORECTAL CANCER – FEASIBILITY STUDY (NIPEC-OXA)","description":"Primary objectives: Analysis of chemotherapy toxicity given through i.p. during NIPEC-OXA throughout the entire treatment period, including a 3-month follow-up.\nPrimary endpoints: Adverse Event meassured by CTCAE 5.0","dates":{"creation":"2021-03-15"},"accession":"2540825","cross_references":{"EU Clinical Trials Register":["2020-004944-27"]}}